FDA issues draft guidance on COPD drug development
The U.S. Food and Drug Administration (FDA) added information on using the St. George’s Respiratory Questionnaire (SGRQ) in its newest version of draft guidance in drug development for Chronic Obstructive Pulmonary Disease (COPD). Read More »